Session 7: Pharmacogenomics

This course will give participants a broad perspective on the emergence of clinical and applied pharmacogenomics (PGx) and provide them with insight into its growing importance in major clinical therapeutic areas.
 
Carolyn Oxencis, PharmD, is a clinical oncology precision medicine and pharmacogenomics pharmacist at Froedtert & the Medical College of Wisconsin. She received her Doctor of Pharmacy degree from the University of Iowa College of Pharmacy and completed a PGY1 Pharmacy Practice Residency at Froedtert Hospital. Dr. Oxencis helped launch the Rare Disease and Precision Medicine Clinic at the F&MCW Clinical Cancer Center in 2022, and is currently piloting a virtual pharmacogenomics consult clinic. She is a Board-Certified Oncology Pharmacist, holds multiple certificates in pharmacogenomics and oncology genomics, and is a member of the Clinical Pharmacogenetic Implementation Consortium (CPIC). Dr. Oxencis is also a Clinical Associate Professor at the MCW School of Pharmacy, and an active member of the Pharmacy Society of Wisconsin (PSW), the American Society of Health-System Pharmacy (ASHP), the American Academy of Colleges of Pharmacy (AACP), and the Hematology Oncology Pharmacy Association (HOPA). Her research interests include clinical pharmacogenomics, oncology precision medicine, genomic health literacy, and patient-reported outcomes (PROs).  

Target Audience

  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Genetic Counselors
  • Researchers
  • Lab Technicians

Learning Objectives

Participants who engage in this education intervention will be able to:

  1. Outline the fundamentals of pharmacogenomics. 
  1. Explore how pharmacogenomics connects to other aspects of clinical pharmacology. 
  1. Discuss strategies for implementing a pharmacogenomic consult service. 
Additional information
AttachmentSize
File PM ED CME_Graduate Program Slides_2023.pptx5.01 MB
PDF icon PGx Reading 1_Roden et al 2019.pdf373.56 KB
PDF icon PGx Reading 2_Chenoweth et al 2020.pdf120.4 KB
PDF icon PGx Reading 3_Haidar et al 2022.pdf1007 KB

Contact

Name: 
Kellie LeGrave
Phone Number: 
+1 (414) 955-4139
Email: 
[email protected]
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
10/20/2025
Course expires: 
10/19/2026
Cost:
$0.00
Part of: 
Precision Medicine Continuing Education Program 2025
This module is presented with a pre-recorded PowerPoint presentation and sound.  An audio lecture is given using visual key points listed on the PowerPoint presentation.  Following the presentation, learners will be asked quiz questions to test retainment of knowledged gained in the presentation. Learners are able to complete the module at their own pace.
Activity Director:
Gwen Lomberk, PhD
 
Planning Committee:
Gwen Lomberk, PhD
John Meurer, MD, MBA
Carolyn Oxencis, PharmD
Jenny Geurts, MS, CGC
 
 
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all persons in control of content must disclose any relevant financial relationships. It is the policy of the Medical College of Wisconsin to identify, mitigate and disclose the absence or presence of all relevant financial relationships with ineligible companies held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education. The following in control of content had no relevant financial relationships to disclose. 
 
  • Gwen Lomberk, PhD
  • John Meurer, MD, MBA
  • Carolyn Oxencis, PharmD
  • Jenny Geurts, MS
  • Jeremy Garrett, PhD
  • Donald Basel, MD
  • Jake Luo, PhD
  • Michael Zimmermann, PhD

 

Name

Company

Role

Deepak Kilari, MD

Eisai, Aveo, Jannsen, Pfizer, Exelixis, MJH Life Science, Aptitude, Targeted Oncology

Consultant, Speaker, Advisory Board

Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Designation of Credit Statement
The Medical College of Wisconsin designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.50 hours of participation for continuing education for allied health professionals.
 
The National Society of Genetic Counselors (NSGC) has authorized The Medical College of Wisconsin to offer up to 1.5 CEUs or 15 Category 1 contact hours for the activity Precision Medicine Continuing Education Program Spring 2025. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.
 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Participation shared with ABP through PARS:
 
Individual participants’ information will be shared with ABP through the ACCME Program and Activity Reporting System (PARS). 

Available Credit

  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.